Genome-wide association studies have demonstrated highly significant associations between polymorphisms in IL-23 pathway genes, notably IL-23R, to a number of chronic inflammatory disorders, including inflammatory bowel disease (IBD) [2], psoriasis [3], and ankylosing spondylitis [4]. Here, IL37 is linked to inflammatory bowel disease.